Lifevantage Corporation (LFVN) USD0.0001

Sell:$12.28Buy:$14.65$0.39 (3.07%)

Prices delayed by at least 15 minutes
Sell:$12.28
Buy:$14.65
Change:$0.39 (3.07%)
Prices delayed by at least 15 minutes
Sell:$12.28
Buy:$14.65
Change:$0.39 (3.07%)
Prices delayed by at least 15 minutes

Company Information

About this company

LifeVantage Corporation is engaged in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. The Company's dietary supplements include its flagship Protandim family of products, LifeVantage Omega+, ProBio, IC Bright, Rise AM, Reset PM, D3+, Daily Wellness, and PhysIQ Fat Burn and Prebiotic dietary supplements. The Protandim product line includes Protandim NRF1 Synergizer, Protandim Nrf2 Synergizer, and Protandim NAD Synergizer. TrueScience is its line of skin and hair care products and Liquid Collagen. The Company also markets and sells Petandim, its companion pet supplement formulated to combat oxidative stress in dogs, and AXIO, its nootropic energy drink mix. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, Spain, Ireland, Singapore, and the Philippines.

Key people

Steven R. Fife
President, Chief Executive Officer, Director
Carl Aure
Chief Financial Officer
Michelle Oborn-Virchow
Chief People Officer
Robert Harris
Chief Technology Officer
Julie Boyster
Chief Marketing Officer
Alissa Neufeld
General Counsel, Corporate Secretary
Kristen Cunningham
Chief Sales Officer
Raymond B. Greer
Independent Chairman of the Board
Rajendran Anbalagan
Independent Director
Michael A. Beindorff
Independent Director
Dayton Judd
Independent Director
Cynthia Latham
Independent Director
Click to see more

Key facts

  • EPIC
    LFVN
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US53222K2050
  • Market cap
    $159.74m
  • Employees
    217
  • Shares in issue
    12.59m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.